Choosing a treatment modality for the infant, child and adolescent with endstage renal disease.
The factors involved in choosing a treatment modality for the infant, child and adolescent with endstage renal disease (ESRD) are different than those utilized when counseling an adult patient. Age at the time ESRD develops, mental status, psychosocial status and the primary renal disease must be taken into consideration when contemplating the optimal therapeutic modality for the pediatric patient with ESRD.
D000293:Adolescent; D000367:Age Factors; D000855:Anorexia / Q000150:complications; D001847:Bone Diseases / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003554:Cystinosis / Q000150:complications / Q000628:therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000150:complications / Q000628:therapy; D006130:Growth Disorders / Q000150:complications; D006801:Humans; D007223:Infant; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D016030:Kidney Transplantation; D010070:Oxalates / Q000378:metabolism; D019815:Oxalic Acid; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011584:Psychology; D009396:Wilms Tumor / Q000150:complications / Q000628:therapy
D010070:Oxalates; D019815:Oxalic Acid